Acquired and inherited thrombophilia in women with unexplained fetal losses

American Journal of Obstetrics and Gynecology

Volumn 187, Issue 5, 2002, Pages 1337-1342

  Alonso, Ana ^a   Soto, Inmaculada ^a   Urgellés, Manuel F ^a   Corte, Jose R ^a   Rodríguez, Maria J ^b   Pinto, Carmen R ^a  

^a Hosp Ctrl Asturias   (Spain)

^b HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

Thrombophilia; Thrombophilic polymorphisms; Unexplained fetal loss

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5 LEIDEN; HOMOCYSTEINE; PHOSPHOLIPID ANTIBODY; PROTEIN C; PROTEIN S; PROTHROMBIN;

ADULT; ANTITHROMBIN III DEFICIENCY; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FETUS DEATH; FETUS WASTAGE; GENE MUTATION; GENETIC DISORDER; GENETIC POLYMORPHISM; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; PREGNANCY COMPLICATION; PREVALENCE; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; STATISTICAL SIGNIFICANCE; THIRD TRIMESTER PREGNANCY; THROMBOPHILIA;

EID: 0036854180     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2002.126849     Document Type: Article

References (24)

1. Clark P, Brennand J, Conkie JA, McCall F, Greer IA, Walker ID. Activated protein C sensitivity, protein C, protein S and coagulation and normal pregnancy. Thromb Haemost 1998;79:1166-70.
2. Greer IA. Thrombosis in pregnancy: Maternal and fetal issues. Lancet 1999;353:1258-65.
3. Bonnar J, Green R, Norris L. Perinatal aspects of inherited thrombophilia. Semin Thromb Hemost 1999;25:481-5.
4. Rosendaal FR. Risk factors for venous thrombosis: Prevalence, risk and interaction. Semin Hematol 1997;34:171-87.
5. Bertina RM, Koeleman BPC, Koster T. Mutation in blood coagulation FV associated with resistance to activated protein C. Nature 1994;369:64-7.
6. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698-703.
7. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: A common mutation in methylentetrahydrofolate reductase. Nat Genet 1995;10:111-3.
8. Rai RS, Regan L, Hadley E, Dave M, Cohen H. Second trimester pregnancy loss is associated with activated protein C resistance. Br J Haematol 1996;92:489-90.
9. Dizon-Towson D, Branch W. Anticoagulant treatment during pregnancy: An update. Semin Thromb Hemost 1998;24(Suppl):55-62.
10. WHO recommended definitions terminology and format for statistical tables related to the perinatal period. Acta Obstet Gynecol Scand 1977;56:247-53.
11. Documentos de Consenso de la Sociedad Española de Obstetricia y Ginecología. Grupo Aborto de Repetición. Madrid: Editorial Meditex; 1996. p. 159-81.
12. Kutteh WH, Park VM, Deitcher S. Hypercoagulable state mutation analysis in white patients with early first-trimester recurrent pregnancy loss. Fertil Steril 1999;71:1048-53.
13. Younis JS, Gonen O, Brenner B, Ben-Ami M. Familial thrombophilia: The scientific rationale for thrombophylaxis in recurrent pregnancy loss. Hum Reprod 1997;12:1389-90.
14. Mello G, Parretti E, Martini E, Mecacci F, La Torte P, Cioni R, et al. Usefulness of screening for congenital or acquired hemostatic abnormalities in women with previous complicated pregnancies. Haemostasis 1999;29:197-203.
15. De Vries JI, Dekker GA, Huijgens PC, Jakobs C, Blomberg BM, Van Geijn HP. Hyperhomocysteinaemia and protein S deficiency in complicated pregnancies. Br J Obstet Gynaecol 1997;104:1248-54.
16. Kupfermic MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999;340:9-13.
17. Martinelli I, Taioli E, Cetin I, Marinoni A, Gerosa S, Villa MV, et al. Mutations in coagulations factors in women with unexplained late fetal loss. N Engl J Med 2000;343:1015-8.
18. Gerhardt A, Scharf RE, Beckmann MW, Struve S, Bender HG, Pillny M, et al. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. N Engl J Med 2000;342:374-80.
19. Greengard JS, Griffin JH, Selighson U. Venous thromboembolism associated with double heterozygosity for R506Q mutation of factor V and for T298M mutation of protein C in a large family of a previously described homozygous protein C deficient newborn with massive thrombosis. Blood 1996;88:877-80.
20. Preston FE, Rosendaal FR, Walker ID, Briet E, Berntorp E, Conard J, et al. Increased fetal loss in women with heritable thrombophilia. Lancet 1996;348:913-6.
21. Brenner B, Sarig G, Weiner Z, Younis J, Blumenfeld Z, Lanir N. Thrombophilic polymorphisms are common in women with fetal loss without apparent cause. Thromb Haemost 1999;82:6-9.
22. Mousa HA, Alfirevic Z. Do placental lesions reflect thrombophilia state in women with adverse pregnancy outcome?. Hum Reprod 2000;15:1830-3.
23. Dizon-Townson DS, Meline L, Nelson LM, Varner M, Ward K. Fetal carriers of the factor V Leiden mutation are prone to miscarriage and placental infarction. Am J Obstet Gynecol 1997;177:402-5.
24. Sebire NJ. Thrombophilias and adverse pregnancy outcome [letter]. Hum Reprod 2001;16:395.